Biotech Distilled
133 companies · 839 active programs
Substack ↗
Subscribe
Therapeutic Areas
Modalities
Phases
Targets
Companies
Home
›
Targets
› KRAS
KRAS
(2 companies · 3 programs)
Companies with an active program directed at KRAS.
Erasca, Inc.
ERAS
ERAS-4001
Phase 1
ERAS-4001
Phase 1
ARVINAS, INC.
ARVN
pan-KRAS degrader
Preclinical